RANI THERAPEUTICS HOLDINGS-A (RANI)
US7530181004 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.88M | 5.86M | 27.00M | 117.50M | 73.10M | |||
| Marketable Securities | 32.70M | 42.67M | 71.50M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 1.70M | |||
| Other Current Assets | 1.81M | 2.31M | 2.40M | 2.10M | 200.00K | |||
| Total Current Assets | 41.39M | 50.85M | 100.90M | 119.60M | 74.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.88M | 6.82M | 7.10M | 4.60M | 4.50M | |||
| Other Non-Current Assets | 246.00K | 246.00K | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 12.12M | 7.07M | 7.10M | 4.60M | 4.50M | |||
| TOTAL ASSETS | 53.51M | 57.92M | 108.00M | 124.20M | 79.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 8.59M | 4.90M | N/A | 0.00 | 1.40M | |||
| Accrued Expenses | 3.98M | 2.39M | 3.30M | 1.40M | 600.00K | |||
| Accounts Payable | 806.00K | 648.00K | 1.50M | 1.10M | 500.00K | |||
| Other Current Liabilities | N/A | 52.00K | 100.00K | 100.00K | 2.90M | |||
| Total Current Liabilities | 13.38M | 7.99M | 4.80M | 2.60M | 5.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 20.85M | 24.48M | 29.10M | 0.00 | 2.40M | |||
| Other Non-Current Liabilities | 4.75M | 0.00 | 100.00K | 0.00 | 300.00K | |||
| Total Non-Current Liabilities | 32.74M | 37.06M | 66.40M | 74.20M | 2.70M | |||
| TOTAL LIABILITIES | 46.11M | 45.05M | 71.20M | 76.80M | 8.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -80.37M | -72.89M | -38.90M | -8.30M | -114.00M | |||
| Additional Paid In Capital | 87.78M | 85.76M | 75.80M | 55.70M | N/A | |||
| Minority Interest | 14.43M | 46.49M | 69.86M | 118.96M | N/A | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | 185.40M | |||
| Other Shareholders' Equity | -11.00K | -12.00K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 48.23M | 47.15M | 49.40M | 49.00M | 48.00M | |||
| Tangible Book Value per Share | 0.15 | 0.27 | 0.75 | 0.97 | -2.36 | |||
| Total Shareholders' Equity | 7.40M | 12.87M | 36.90M | 47.40M | 71.40M | |||
| TOTAL LIABILITIES AND EQUITY | 53.51M | 57.92M | 108.00M | 124.20M | 79.40M | |||
| Statistics | ||||||||
| Debt/Equity | 2.82 | 1.90 | 0.79 | N/A | 0.03 | |||
| Current Ratio | 3.09 | 6.36 | 21.02 | 46.00 | 14.13 | |||
| Return On Assets (ROA) | -61.82% | -58.65% | -28.32% | -6.71% | -21.03% | |||
| Return On Equity (ROE) | -447.16% | -264.03% | -82.90% | -17.57% | -23.39% | |||
All data in USD